trimethadione

Trimethadione
Systematic (IUPAC) name
3,5,5-trimethyl-1,3-oxazolidine-2,4-dione
Identifiers
CAS number	127-48-0
ATC code	N03AC02
PubChem	5576
DrugBank	APRD00315
Chemical data
Formula	C6H9NO3
Mol. mass	143.141
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	X
Legal status	℞ Prescription only
Routes	?

Trimethadione is an oxazolidinedione anticonvulsant. It is used to treat epileptic conditions that are resistant to other treatments; recent studies by Doctor Jianxin Bao, Ph.D., at Washington University in Saint Louis's Central Institute For The Deaf's Center For Presbyacusis and Aging suggest that trimethadione, along with other oxazolidinedione anticonvulsant medications may be useful in treating sensorineural hearing loss cases like those of Iraq war veterans- if the drug's side effects, like dizziness, can be lessened by modifying the drug so it does not cross into the brain itself.

If administered during pregnancy, fetal trimethadione syndrome may result causing Facial Dysmorphism(short upturned nose,slanted eyebrows), cardiac defects,Intra Uterine Growth Retardation,mental retardation. The fetal loss rate while using trimethadione has been reported to be as high as 87%.^[1]

References

External links

• MedlinePlus DrugInfo medmaster-a601127
• DDB 30479

Donate to Wikimedia